Pharmacology

Action Mechanism of Action Reference
INHIBITOR TNF-alpha inhibitor DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Spondylitis, Ankylosing 4 D013167 ClinicalTrials
Psoriasis 4 D011565 ClinicalTrials
Severe Acute Respiratory Syndrome 3 D045169 ClinicalTrials
Arthritis, Juvenile 3 D001171 ClinicalTrials
Pyoderma 3 D011711 ClinicalTrials
Hidradenitis Suppurativa 3 D017497 ClinicalTrials
Uveitis 3 D014605 ClinicalTrials
Inflammatory Bowel Diseases 3 D015212 ClinicalTrials
Behcet Syndrome 3 D001528 ClinicalTrials
Giant Cell Arteritis 3 D013700 ClinicalTrials
Cystitis, Interstitial 3 D018856 ClinicalTrials
Crohn Disease 3 D003424 ClinicalTrials
Osteoarthritis 3 D010003 ClinicalTrials
Wet Macular Degeneration 2 D057135 ClinicalTrials
Osteoarthritis, Knee 2 D020370 ClinicalTrials
Dupuytren Contracture 2 D004387 ClinicalTrials
Netherton Syndrome 2 D056770 ClinicalTrials
Sarcoidosis 2 D012507 ClinicalTrials
Sciatica 2 D012585 ClinicalTrials
Colitis 2 D003092 ClinicalTrials
Glomerulosclerosis, Focal Segmental 2 D005923 ClinicalTrials
Inflammation 2 D007249 ClinicalTrials
Asthma 2 D001249 ClinicalTrials
Thyroid Neoplasms 1 D013964 ClinicalTrials
Mucopolysaccharidoses 1 D009083 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL1201580
FDA SRS FYS6T7F842